Solid Biosciences LLC (SLDB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $763.42M
Last updated: Nov 17, 2026 at 11:05 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 9.0% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 46.8, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about SLDB
GNG News
All SLDB newsNews
SLDB Valuation
- P/FCF
- -4.9x
- P/B
- 2.9x
SLDB Profitability: Margins, ROIC and FCF
Solid Biosciences LLC (SLDB) has an operating margin of 0.0% and a net margin of 0.0%.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -76.9%
- FCF yield
- -20.5%
Solid Biosciences LLC Competitors
The companies most similar to Solid Biosciences LLC (SLDB) include Sana Biotechnology, Syndax Pharmaceuticals and DBV Technologies.
Sector: Healthcare
Companies most similar to Solid Biosciences LLCSLDB Analyst Ratings
Solid Biosciences LLC (SLDB) has a Buy consensus from 14 analysts: 14 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.
- Consensus
- Buy
- Analysts
- 14
- Strong Buy
- 5
- Buy
- 9
- Hold
- 0
- Sell
- 0
- Strong Sell
- 0
SLDB Bull Case vs Bear Case
Bull case
- 100.0% of SLDB's analyst ratings are Buy or Strong Buy.
Bear case
- SLDB beat EPS estimates in 37.5% of its last 8 reported quarters.
- SLDB's quarterly revenue changed -100.0% year over year.
SLDB Earnings: Beat Rate and Next Report
Solid Biosciences LLC (SLDB) beat the EPS estimate in 3 of the last 8 quarters (37.5%). Its next report is expected on Mar 4, 2027.
- Beat rate
- 3 of 8 quarters (37.5%)
- Average surprise
- -4.9%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.41
SLDB Earnings Date
SLDB reports Mar 4, 2027. The date is estimated.
SLDB ETF Holders
GNG tracks 10 ETFs that hold SLDB. The largest weights:
- State Street SPDR S&P Biotech ETF (XBI), 0.11% of the fund
- Fidelity Enhanced Small Cap Core ETF (FESM), 0.05% of the fund
- iShares Biotechnology ETF (IBB), 0.04% of the fund
- iShares Russell 2000 ETF (IWM), 0.02% of the fund
- Vanguard Health Care Index Fund ETF Shares (VHT), 0.01% of the fund
Updated Nov 4, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About SLDB
When does SLDB report earnings?
Solid Biosciences LLC (SLDB) is expected to report earnings on Mar 4, 2027.
Does SLDB pay dividends?
Solid Biosciences LLC (SLDB) does not currently pay a regular dividend.
What is SLDB's market cap?
Solid Biosciences LLC (SLDB) has a market capitalization of $763.42M with a current stock price of $6.48.
SLDB pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.